Does RISANKIZUMAB-RZAA Cause Flatulence? 202 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Flatulence have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
202
Reports of Flatulence with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
1
Deaths
67
Hospitalizations
How Dangerous Is Flatulence From RISANKIZUMAB-RZAA?
Of the 202 reports, 1 (0.5%) resulted in death, 67 (33.2%) required hospitalization.
Is Flatulence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 202 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Flatulence?
ADALIMUMAB (1,651)
POLYETHYLENE GLYCOL 3350 (1,207)
VEDOLIZUMAB (949)
SEMAGLUTIDE (925)
TIRZEPATIDE (918)
LENALIDOMIDE (865)
NINTEDANIB (832)
DULAGLUTIDE (754)
OCTREOTIDE (699)
APREMILAST (617)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Flatulence Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA